- Home
- IDXX
as 11-15-2024 4:00pm EST
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
| Founded: | 1983 | Country: | United States |
| Employees: | N/A | City: | WESTBROOK |
| Market Cap: | 35.5B | IPO Year: | 1991 |
| Target Price: | $545.29 | AVG Volume (30 days): | 798.2K |
| Analyst Decision: | Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 10.36 | EPS Growth: | 5.57 |
| 52 Week Low/High: | $404.74 - $583.39 | Next Earning Date: | 10-31-2024 |
| Revenue: | $3,844,817,000 | Revenue Growth: | 7.16% |
| Revenue Growth (this year): | 8.03% | Revenue Growth (next year): | 6.98% |
Stock Insider Trading Activity of IDEXX Laboratories Inc. (IDXX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| SZOSTAK M ANNE | IDXX | Director | Sep 5 '24 | Sell | $469.37 | 500 | $234,686.15 | 0 |
Latest IDEXX Laboratories Inc. News
IDXX Breaking Stock News: Dive into IDXX Ticker-Specific Updates for Smart Investing
Simply Wall St.
2 days ago
IDEXX Laboratories (NASDAQ:IDXX) shareholders have earned a 10% CAGR over the last five years
Argus Research
5 days ago
IDXX: Raising target price to $447.00
Simply Wall St.
7 days ago
Is It Time To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?
Insider Monkey
10 days ago
Is IDEXX Laboratories (IDXX) The Best Pet Stock To Invest In According To Analysts?
Simply Wall St.
11 days ago
Could The Market Be Wrong About IDEXX Laboratories, Inc. (NASDAQ:IDXX) Given Its Attractive Financial Prospects?
Motley Fool
11 days ago
Is It Time to Buy October's Worst-Performing Nasdaq Stocks?
Argus Research
12 days ago
IDXX: Lowering target price to $437.00
Motley Fool
12 days ago
A Once-in-a-Decade Opportunity: 1 Super S&P 500 Stock Down 40% to Buy After Its Recent Pullback
Compare IDXX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IDXX IDEXX Laboratories Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.